Ronald Harold Wilfred Cooper - 18 Jan 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 15:49:00 UTC
Previous filing
20 Sep 2021
Next filing
25 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALBO Stock Option (right to buy) Award $0 +132,150 $0.000000 132,150 18 Jan 2022 Common Stock 132,150 $26.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.